Antitumor activity of iRGD-modified red blood cell membrane nanoparticles loaded with Juglone and Oxaliplatin against colorectal cancer
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Department of Oncology, Kunshan Traditional Chinese Medicine Hospital, Kunshan, Jiangsu, China
Department of Oncology, First People's Hospital of Yancheng, Fourth Affiliated Hospital of Nantong University, Yancheng, Jiangsu, China.
The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, Jiangsu, China
Funding
Health and Family Planning Commission key program of Nanjing · Health and Family Planning Commission development program of Jiangsu Province · Livelihood Science and Technology - Basic research on Medical and Health application program of Suzhou